Skip to content
FrontierPicks

Dossiers · 225 published · 225 with a kill line · 7 archetypes · 17 themes

Thesis. Kill line. Catalyst. Per ticker.

A full research note on every stock we cover: what the model thinks and why, the case for and against, the dates that matter and the price that would prove it wrong. Written by Claude Opus from each company's filings, releases, news and analyst moves, and dated, so you always know how fresh it is.

Watch lists

Conviction mix

  1. Medium 127 · 56%
  2. Low 98 · 44%

Archetype mix

  1. Theme leader 44 · 20%
  2. Picks and shovels 39 · 17%
  3. Second-order beneficiary 26 · 12%
  4. Business pivot 68 · 30%
  5. Event-driven 24 · 11%
  6. Crowd-driven 2 · 1%
  7. Distinct case 22 · 10%

Freshness · last analysed

  1. ≤ 7 days 197 · 88%
  2. ≤ 30 days 28 · 12%

conviction highmediumlownone

225 shown

No dossiers match your filters.

In the portfolio

14
AMD Advanced Micro Devices, Inc. Medium Advanced Micro Devices says AI chip demand exceeds its supply and is lining up Samsung memory to meet it, but reports on 8 October 2026 that OpenAI's revenue is lower than believed hit the shares. The 3 November 2026 third-quarter report… Picks and shovels · AI chips & memory · AI datacenter infrastructure catalyst · ANET Arista Networks, Inc. Medium Arista Networks is turning AI data-center spending into about 40% revenue growth on raised 2026 guidance of roughly $12.6 billion. The third-quarter report on 3 November 2026 shows whether revenue reaches the $3.3 billion guide and gross… Picks and shovels · Networking & optical catalyst · GOOGL Alphabet Inc. Medium Alphabet's Google Cloud, growing 82% with a $514 billion backlog and wide enterprise Gemini adoption, carries the case for the shares against 2026 capex of up to $205 billion. The 28 October 2026 third-quarter report shows whether cloud… Theme leader · Mega-cap AI platforms · AI datacenter infrastructure catalyst · LITE Lumentum Holdings Inc. Medium Demand for Lumentum Holdings' AI data-center lasers exceeds what it can ship, per Stifel on 5 October 2026, and the 8 October 2026 optics selloff cut no estimates; the 5 November 2026 report decides whether revenue confirms the… Picks and shovels · Networking & optical catalyst · LLY Eli Lilly and Company Medium Eli Lilly's tirzepatide drugs still drive fast sales growth and analysts keep raising targets, yet the shares closed 8.6% below their 52-week high on 8 October 2026. The 29 October 2026 third-quarter report shows whether revenue clears the… Theme leader · Precision biotech & therapeutics catalyst · MRVL Marvell Technology, Inc. Medium Marvell Technology's growth case strengthened at its 6 October 2026 Investor Day, which set a $70–90 billion fiscal 2031 revenue target against a $47 billion consensus. Alphabet's 28 October 2026 spending guidance and the early-December… Picks and shovels · Networking & optical catalyst · MS Morgan Stanley Medium Morgan Stanley's shares have fallen further than its record second-quarter earnings support, closing at $187.44 on 8 October 2026; the 14 October 2026 third-quarter report shows whether wealth flows and the $20 billion buyback outweigh… Business pivot catalyst · MU Micron Technology, Inc. Medium Micron Technology's fiscal Q1 2027 guide of $61.5 billion in revenue, about $5 billion above consensus and backed by roughly $150 billion of contracts, still carries the case despite this week's memory selloff and Taiwan strike vote. The… Picks and shovels · AI chips & memory catalyst · NVDA NVIDIA Corporation Medium NVIDIA's data-center demand has to carry October-quarter revenue to its $108.0 billion outlook as doubts grow over how AI buyers fund their purchases; NVIDIA's 17 November 2026 fiscal third-quarter report settles the case. Picks and shovels · AI chips & memory catalyst · SNDK Sandisk Corporation Medium Sandisk's contract-backed AI storage recovery still has rising NAND prices behind it, but memory shares now fall even on record peer results. Sandisk's 29 October 2026 fiscal Q1 2027 report settles the case if revenue reaches $10.3 billion… Picks and shovels · AI chips & memory catalyst · SNX TD SYNNEX Corporation Medium TD SYNNEX's Hyve AI server unit is driving earnings and guidance well above forecasts while the business burns cash; the fiscal Q4 report (~January 2027) settles whether that profit turns into positive operating cash flow. Second-order beneficiary · AI datacenter infrastructure catalyst · TSM Taiwan Semiconductor Manufacturing Company Ltd. Medium Taiwan Semiconductor Manufacturing's third-quarter sales of about NT$1.49 trillion beat its own guidance, so the case now rests on margin; the 15 October 2026 report decides whether gross margin holds 65% and fourth-quarter guidance keeps… Picks and shovels · Semi foundry & equipment catalyst · DELL Dell Technologies Inc. Low Dell Technologies trades near its high on expectations that its record $95 billion AI-server backlog converts to revenue at a 15% server margin; fiscal third-quarter results, listed for about 24 November 2026, test that against the $49.0… Picks and shovels · AI datacenter infrastructure catalyst · STX Seagate Technology Holdings PLC Low Seagate Technology's hard-drive pricing power is being priced as at risk as supply headlines push the shares lower; the ~28 October 2026 fiscal Q1 report shows whether revenue reaches the $4.10 billion guide and nearline pricing holds. Picks and shovels · AI chips & memory · AI datacenter infrastructure catalyst ·

Watching

201
AAMI Acadian Asset Management Inc. Medium Acadian Asset Management's rerating rests on ten straight quarters of client inflows lifting fees and margins. Its third-quarter report, expected around 29 October 2026, shows whether flows stayed positive and fees held at least $176.5… Business pivot catalyst · ABBV AbbVie Inc. Medium AbbVie's growth rests on Skyrizi and Rinvoq, which more than offset Humira's decline and back 2026 revenue guidance of about $67.6 billion. The 30 October 2026 third-quarter report shows whether both drugs still grow above 20%. Business pivot · Oncology & immunology · Precision biotech & therapeutics catalyst · ADPT Adaptive Biotechnologies Corporation Medium Adaptive Biotechnologies' clonoSEQ test won NCCN and International Myeloma Society backing in September 2026, yet the shares slid to $26.09 by 8 October 2026; the Q3 report, expected around 4 November 2026, shows whether test volume… Distinct case · Medtech & diagnostics catalyst · ALVO Alvotech Medium Alvotech's shares turn on FDA approval of its Simponi and Eylea biosimilars, reported due 4 December 2026. The 5 October 2026 FDA clearance of more U.S. output from its Reykjavik plant makes approval likelier, and a manufacturing-related… Event-driven · Binary-catalyst biotech analysed · AMAT Applied Materials, Inc. Medium Applied Materials' chip-equipment recovery case holds as TSMC's September revenue rose 54.6% and Micron raises spending; the 13 October 2026 SEMICON West briefing, TSMC's 15 October 2026 results and the ~12 November 2026 report against a… Picks and shovels · Semi foundry & equipment · AI chips & memory catalyst · AMPL Amplitude, Inc. Medium Amplitude's shares hit a new 52-week closing high of $15.29 on 8 October 2026 on a raised outlook and 21% revenue growth. The third-quarter report, expected around 4 November 2026, settles the case by testing revenue against $105.6–108.0… Second-order beneficiary · AI enterprise software catalyst · AOUT American Outdoor Brands, Inc. Medium American Outdoor Brands' 53.0% gross margin, raised profit guidance and $10 million buyback still support the shares, which closed at $16.30 on 8 October 2026; the fiscal second-quarter report, expected around 3 December 2026, shows… Distinct case · Consumer discretionary rotation catalyst · ASML ASML Holding N.V. Medium ASML Holding's raised €43–45 billion 2026 sales outlook and rising memory-maker spending support its lithography upturn; third-quarter sales against the €11.0–12.0 billion guide on 14 October 2026 settle the near-term case. Picks and shovels · Semi foundry & equipment · AI chips & memory catalyst · AZTA Azenta, Inc. Medium Azenta's recovery case rests on its 9% June-quarter organic growth repeating and on an $11 million cost-cut plan announced in October; the fiscal fourth-quarter report, expected around 20 November 2026, shows whether revenue and free cash… Business pivot · Medtech & diagnostics analysed · BWLP BW LPG Limited Medium BW LPG Limited's dividend case rests on VLGC spot freight near $198,000 a day, more than double the ~$88,000 booked for Q3; the 24 November 2026 report must show Q3 shipping earnings above $74,000 a day and a dividend of at least $0.95. Theme leader · Freight & logistics · Oil, energy & geopolitical catalyst · CAI Caris Life Sciences, Inc. Medium Caris Life Sciences is growing revenue faster than its 27–28% FY2026 guidance implies, though a steep fourth-quarter 2025 comparison narrows the room for a raise; the third-quarter report expected around 4 November 2026 shows whether… Second-order beneficiary · Medtech & diagnostics catalyst · CDNA CareDx, Inc. Medium CareDx's shares have more than doubled in three months on a raised 2026 revenue guide and a higher preliminary Medicare rate for AlloSure; the third-quarter report, expected around 3 November 2026, tests whether revenue stays on track for… Event-driven · Medtech & diagnostics catalyst · CIEN Ciena Corporation Medium Ciena Corporation's AI-driven optical order book, with backlog expected above $10 billion, has lifted the shares off their September lows. The fiscal-fourth-quarter report, estimated for about 10 December 2026, settles the case: revenue… Picks and shovels · Networking & optical analysed · CLDT Chatham Lodging Trust Medium Chatham Lodging Trust's summer RevPAR growth of 8%–10% a month, led by its Silicon Valley hotels, runs far ahead of its 1.5%–3.0% full-year guidance. The third-quarter report, expected around 4 November 2026, shows whether earnings and the… Second-order beneficiary · Travel & leisure catalyst · CLMT Calumet, Inc. Medium Calumet's case rests on Montana Renewables lifting sustainable aviation fuel output above an 80 million gallon annual run-rate by year-end 2026 for $137 million of remaining capital. The third-quarter report on 6 November 2026 is the next… Business pivot · Biofuels & low-carbon fuels · Oil, energy & geopolitical catalyst · CLS Celestica, Inc. Medium Celestica's AI datacenter hardware business is still growing fastest, but its shares fell to $356.53 on 8 October 2026 with no company news; the 26 October 2026 report must hit $5.25–$5.55 billion revenue and keep the $20.5 billion 2026… Picks and shovels · AI datacenter infrastructure catalyst · CMBT CMB.TECH NV Medium CMB.TECH's case now rests on record crude-tanker rates feeding fourth-quarter earnings and further vessel-sale gains, after shareholders approved the $0.64-per-share payout on 8 October 2026; the 22 October 2026 payment and the 26 November… Business pivot · Freight & logistics · Oil, energy & geopolitical catalyst · COHU Cohu, Inc. Medium Cohu's AI-driven chip-test recovery has lifted the shares to $68.37, level with the $70.88 average analyst target; the Q3 report, expected about 29 October 2026, and the 10 November 2026 investor day show whether revenue and new targets… Picks and shovels · Semi foundry & equipment catalyst · CRDO Credo Technology Group Holding Ltd Medium Credo Technology's revenue is still more than doubling and management expects optical products to lift second-half fiscal 2027 growth. The early-December fiscal second-quarter report settles it: revenue at or above the $525 million… Picks and shovels · Networking & optical catalyst · CRSR Corsair Gaming, Inc. Medium Corsair Gaming's margin recovery has lifted profit estimates and a 38.2% three-month share gain; the third-quarter report, estimated for 3 November 2026, decides whether margins hold without the tariff refund and against rising memory… Business pivot · Consumer discretionary rotation catalyst · CRWD CrowdStrike Holdings, Inc. Medium CrowdStrike's record second-quarter subscription growth and AI-agent security demand still support the shares after a 5.7% pullback from their 6 October 2026 high. The ~1 December 2026 third-quarter report decides whether net new annual… Theme leader · Cybersecurity analysed · CSCO Cisco Systems, Inc. Medium Cisco Systems' AI-networking orders point to faster fiscal 2027 revenue, and its shares have recovered to $114.89 from a late-September slide. The first-quarter report, expected around 10 November 2026, shows whether $9.3 billion of AI… Business pivot · Networking & optical · AI datacenter infrastructure analysed · CSTL Castle Biosciences, Inc. Medium Castle Biosciences' recovery rests on its TissueCypher Barrett's esophagus test growing volume 50–52% inside a $365–375 million 2026 revenue range. The third-quarter report, expected around 2 November 2026, tests both with the shares 21.7%… Distinct case · Medtech & diagnostics catalyst · CVX Chevron Corporation Medium Chevron looks modestly more likely to beat the S&P 500 than lag it as Brent crude returns above $105 and refining lifts third-quarter earnings. The 30 October 2026 report settles whether downstream earnings rose and buybacks held within… Theme leader · Oil, energy & geopolitical catalyst · CYRX CryoPort, Inc. Medium Cryoport's cell and gene therapy cold-chain business turned to positive adjusted EBITDA in Q2, and its shares have cooled to $16.90 from an $18.14 high. The ~4 November 2026 third-quarter report shows whether that profit repeats and… Picks and shovels · Precision biotech & therapeutics · Rare disease & gene therapy catalyst · DCTH Delcath Systems, Inc. Medium Delcath Systems' self-funded growth in its HEPZATO liver-cancer treatment supports its raised $104–108 million 2026 revenue outlook. Third-quarter results, expected around early November, show whether that guidance survives the summer… Distinct case · Oncology & immunology catalyst · DINO HF Sinclair Corporation Medium HF Sinclair's shares closed at a 52-week high of $120.72 on 8 October 2026 as record third-quarter diesel margins lift estimates such as UBS's $8.30 a share; the 28 October 2026 report shows whether refining margin beat the second… Theme leader · Oil, energy & geopolitical catalyst · DXCM DexCom, Inc. Medium DexCom's wider operating margins and analyst targets up to Barclays' $115 support the case with the shares at $84.41 on 8 October 2026; Dexcom's confirmed 29 October 2026 report shows whether fiscal 2026 revenue guidance rises above $5.250… Distinct case · Medtech & diagnostics catalyst · ECO Okeanis Eco Tankers Corp. Medium Record supertanker freight in October 2026 points to Okeanis Eco Tankers earning far above the rates it booked by August. The 11 November 2026 report and its fourth-quarter bookings show whether that holds, and a Strait of Hormuz reopening… Distinct case · Oil, energy & geopolitical catalyst · FPS Forgent Power Solutions, Inc. Medium Forgent Power Solutions' $3.0 billion backlog and above-consensus fiscal 2027 guidance still run ahead of its shares, which closed at $39.80 on 8 October 2026, below the $49 July offering price. The mid-November first-quarter report and… Second-order beneficiary · AI datacenter infrastructure catalyst · FRO Frontline Plc Medium Frontline's shares are back at a 52-week high because renewed Gulf tanker attacks keep crude-carrier rates high. The 30 November 2026 third-quarter report shows whether achieved VLCC earnings held the second quarter's $152,700 per day. Theme leader · Oil, energy & geopolitical analysed · FROG JFrog Ltd. Medium JFrog's 29% second-quarter revenue growth and raised $648M-$652M full-year guide keep its shares 6.5% under their 52-week closing high. The third-quarter report expected around 5 November 2026 decides whether JFrog raises that guide again… Second-order beneficiary · Cybersecurity · AI enterprise software catalyst · FTK Flotek Industries, Inc. Medium Flotek Industries' case rests on international chemistry demand, which lifted 2026 revenue guidance to $360–370 million, and on analytics earning half of gross profit; the early-November third-quarter report shows whether both hold. Business pivot · Oil, energy & geopolitical catalyst · FTNT Fortinet, Inc. Medium Fortinet's firewall refresh and raised 2026 guidance hold the shares near their $191.27 52-week high, above the consensus analyst target; the 28 October 2026 third-quarter report shows whether billings and product revenue justify that… Second-order beneficiary · Cybersecurity catalyst · GME GameStop Corp. Class A Medium GameStop's CEO Ryan Cohen has bought shares four times on the open market since 10 September, at rising prices, backing a cash-rich balance sheet and fast-growing collectibles sales. EBay's 4 November report and GameStop's December results… Business pivot · Consumer discretionary rotation catalyst · GS The Goldman Sachs Group, Inc. Medium Goldman Sachs shares, 23.0% below their 52-week high and oversold after a mid-September trading warning, already price in a weaker quarter; the 13 October 2026 third-quarter report shows whether earnings hold within the $13.87 to $15.39… Theme leader catalyst · GTLB GitLab Inc. Medium GitLab's usage-based pricing for coding agents has to lift revenue above its $281–$283 million fiscal Q3 guidance, and the early-December report settles it. The shares closed at a 52-week high of $53.56 on 8 October 2026, above the $53.16… Second-order beneficiary · AI enterprise software catalyst · HAE Haemonetics Corporation Medium The 5 November 2026 second-quarter report must put a revenue figure on that rollout. Business pivot · Medtech & diagnostics catalyst · HALO Halozyme Therapeutics, Inc. Medium Halozyme Therapeutics' royalty growth, up 50% to $307.7 million in the second quarter, and a 7 October 2026 Dutch patent win over Merck support shares 4.7% below their high. Partner reports from 13 October 2026 and Halozyme's third-quarter… Picks and shovels · Precision biotech & therapeutics catalyst · HPE Hewlett Packard Enterprise Company Medium Hewlett Packard Enterprise is being repriced as a networking-led AI infrastructure company and now trades at the $72.06 consensus target. The 3 December 2026 fiscal fourth-quarter report shows whether the raised networking outlook and $1.2… Business pivot · AI datacenter infrastructure · Networking & optical catalyst · HTFL Heartflow, Inc. Medium Heartflow's AI coronary-scan revenue grew 48% in the second quarter of 2026, and its full-year outlook rose to $246–250 million. The third-quarter report, expected around 12 November 2026, tests that outlook after the shares slipped 8.8%… Theme leader · Medtech & diagnostics analysed · IBRX ImmunityBio, Inc. Medium ImmunityBio's bladder-cancer drug Anktiva grew Q2 2026 net product revenue 92% year over year to $50.7 million, which keeps supporting the shares despite directors selling in October. Third-quarter revenue, due in a possible October… Event-driven · Precision biotech & therapeutics catalyst · IBTA Ibotta, Inc. Medium Ibotta's third-party publisher network has returned the company to revenue growth and lifted the shares to a 52-week high of $43.28 on 8 October 2026; the Q3 2026 report on 2 November 2026 settles whether revenue clears the $86 million low… Distinct case catalyst · INTU Intuit Inc. Medium Intuit's QuickBooks became a launch connector inside Meta's Muse agent on 6 October 2026, easing the main fear that AI agents would take its customers. The fiscal Q1 report expected around 19 November 2026 shows whether new-customer growth… Business pivot · AI enterprise software · Fintech & consumer credit analysed · IOVA Iovance Biotherapeutics, Inc. Medium Iovance Biotherapeutics' raised FY2026 revenue guidance of $410–420 million, set two days before Q3 closed, still carries the case after a 229.5% three-month rise. The early-November Q3 report shows whether Amtagvi revenue confirms it. Theme leader · Precision biotech & therapeutics catalyst · ISRG Intuitive Surgical, Inc. Medium Intuitive Surgical's revenue grew 19% last quarter while its shares trade 29.9% below their 52-week high; the 20 October 2026 third-quarter report shows whether procedure growth holds inside the 13.5%–15.5% full-year guidance. Theme leader · Medtech & diagnostics catalyst · JPM JPMorgan Chase & Co. Medium JPMorgan Chase's case is a capital-markets upswing guided at mid-to-high-teens growth, and its 13 October 2026 third-quarter report shows whether earnings confirm it against a $5.93 EPS consensus. The shares closed at $331.42 on 8 October… Theme leader catalyst · LFST LifeStance Health Group, Inc. Medium LifeStance Health's third-quarter profit guidance of $49–59 million sits below its $66.0 million second-quarter result, while the shares trade under September's $12.35 offering price; the report expected around 5 November 2026 shows… Business pivot · Managed care & health services catalyst · LPG Dorian Lpg Ltd Medium Dorian LPG has 99% of its September quarter fixed above $88,000 a day, setting up record results around 5 November 2026; US claims that oil again moves through Hormuz are the main threat to rates after that. Theme leader · Freight & logistics · Oil, energy & geopolitical catalyst · LRCX Lam Research Corporation Medium Lam Research's recovery case rests on record memory profits, such as Samsung's 8 October 2026 guidance, turning into etch and deposition tool orders; the 21 October 2026 report settles it, needing revenue at or above the $8.10 billion… Picks and shovels · Semi foundry & equipment · AI chips & memory catalyst · LTRX Lantronix, Inc. Medium Lantronix is becoming a supplier of computing modules for military drones, backed by a Pentagon Blue UAS listing on 1 October 2026; the fiscal first-quarter report around 4 November 2026 shows whether revenue meets the $31–33 million guide. Business pivot · Analog semiconductors catalyst · MA Mastercard Incorporated Medium Mastercard's earnings are growing faster than its share price, which stablecoin and swipe-fee legislation fears hold back; the 29 October 2026 third-quarter report shows whether 12% cross-border and 20% services growth held up. Business pivot · Fintech & consumer credit catalyst · MANE Veradermics, Incorporated Medium Veradermics' oral minoxidil tablet VDPHL01 has one strongly positive hair-loss trial, and its shares closed at $126.63 on 8 October 2026 after recovering the 6 October 2026 drop. Study '304', guided for the second half of 2026, settles… Event-driven · Binary-catalyst biotech analysed · META Meta Platforms, Inc. Medium Meta Platforms' Muse AI agent drew 5.6 million downloads in under four weeks, and the third-quarter report expected 28 October 2026 shows whether that uptake becomes disclosed revenue or paid users. A New Mexico privacy-penalty ruling,… Theme leader · Mega-cap AI platforms catalyst · MGNI Magnite, Inc. Medium Magnite's connected-TV growth and Google's court-ordered ad-exchange remedies hold the shares within 1% of a 52-week high; the 4 November 2026 third-quarter report shows whether results confirm the raised 2026 outlook. Second-order beneficiary catalyst · MRK Merck & Co., Inc. Medium Merck's newer drugs, led by Winrevair's 75% second-quarter sales growth and the July launch of the oral cholesterol pill Lipfendra, are reducing its reliance on Keytruda. The 29 October 2026 third-quarter report shows whether sales confirm… Business pivot · Oncology & immunology · Precision biotech & therapeutics catalyst · MSFT Microsoft Corporation Medium Microsoft's AI-platform case turns on Azure meeting its 44–45% constant-currency growth outlook in the fiscal Q1 FY27 report Microsoft confirmed for 28 October 2026. After a 33.9% three-month rise and an 8 October drop on OpenAI revenue… Theme leader · Mega-cap AI platforms · AI enterprise software catalyst · MTW The Manitowoc Company, Inc. Medium Manitowoc's crane-order recovery still supports the shares after a pullback to $21.72; the third-quarter report, expected about 5 November 2026, shows whether backlog holds $1,050.1 million and the $150–170 million EBITDA guidance survives. Distinct case · Cyclical industrials catalyst · NBIS Nebius Group N.V. Medium Nebius Group's case rests on GPU rental price increases of 17–21% from 1 October lifting revenue toward its $3.0–3.4 billion 2026 forecast. The third-quarter report, expected about 11 November 2026, shows whether the higher prices reach… Theme leader · GPU cloud & neoclouds · AI datacenter infrastructure catalyst · NEO NeoGenomics, Inc. Medium NeoGenomics pre-announced third-quarter revenue of about $209 million, above consensus, and flagged a higher full-year guide, yet its shares slid to $16.02 after a CEO handover; the report expected 27 October 2026 shows how far guidance… Business pivot · Medtech & diagnostics · Precision biotech & therapeutics catalyst · NEOG Neogen Corporation Medium Neogen's turnaround now has numbers behind it: a first-quarter beat, a raised fiscal 2027 revenue guide of $885–890 million and a 30% margin target for fiscal 2031. Clearance of the Genomics sale to Zoetis, expected by December 2026,… Business pivot · Medtech & diagnostics analysed · NOW ServiceNow, Inc. Medium ServiceNow's AI products passed $1 billion in annual contract value and second-quarter subscription revenue grew 24.5%; the confirmed 28 October 2026 third-quarter report shows whether growth holds near the guided 20.5% and margins reach… Second-order beneficiary · AI enterprise software catalyst · NSIT Insight Enterprises, Inc. Medium Insight Enterprises is an earnings-upgrade story built on fast cloud and services profit growth and adjusted EPS guidance raised to $12.20–$12.70 on 6 August 2026; the third-quarter report, expected about 29 October 2026, shows whether… Business pivot · AI datacenter infrastructure catalyst · NTSK Netskope, Inc. Medium Netskope's 29% revenue growth and raised fiscal 2027 outlook keep its shares just above the $19.08 average analyst target. The fiscal Q3 report expected around 10 December 2026 decides whether revenue clears the $227–229 million guidance. Distinct case · Cybersecurity analysed · OCC Optical Cable Corporation Medium Optical Cable Corporation's data-center orders lifted third-quarter sales 22.0% and gross margin to 37.4%, but backlog stalled at $13.5 million. The fourth-quarter report, expected around mid-December 2026, will show whether growth holds… Business pivot · Networking & optical analysed · ODD ODDITY Tech Ltd. Medium ODDITY Tech's guidance for third-quarter revenue down only about 5%, set on 9 September 2026 after beating its own second-quarter targets, keeps the beauty company a recovery case; the third-quarter report, expected around 17 November… Event-driven · Consumer discretionary rotation analysed · OMER Omeros Corporation Medium Omeros Corporation's case rests on YARTEMLEA net product sales growing past the second quarter's $28.5 million; the third-quarter 2026 report, expected around 12 November 2026, settles it. Theme leader · Precision biotech & therapeutics · Rare disease & gene therapy analysed · ONON On Holding AG Medium On Holding's 2029 goal of at least CHF 5.6 billion in sales and its first $1 billion buyback have lifted the shares off their 52-week low. The Q3 report, expected around 10 November 2026, will show whether growth holds near the company's… Theme leader · Consumer discretionary rotation analysed · ONTO Onto Innovation Inc. Medium Onto Innovation's case rests on Atlas G6 inspection orders lifting third-quarter revenue to at least $380 million, its guidance floor; TSMC's 15 October 2026 report is the first test, and Onto's own report, expected 29 October to 5… Picks and shovels · Semi foundry & equipment catalyst · OPRT Oportun Financial Corporation Medium Oportun Financial's shares closed at a 52-week high of $8.66 on 8 October 2026 after a profit repair that beat guidance in Q2 2026; the Q3 report, estimated for 3 November 2026, decides whether charge-offs near 11.0% and adjusted EBITDA of… Business pivot · Fintech & consumer credit catalyst · PANW Palo Alto Networks, Inc. Medium Palo Alto Networks' case rests on AI security demand lifting its $14.10B–$14.20B fiscal 2027 revenue outlook. The shares closed at $398.50 on 8 October 2026, 5.1% under the 6 October 2026 record, and the fiscal Q1 report expected about 19… Theme leader · Cybersecurity catalyst · PAYS Paysign, Inc. Medium Paysign's fast-growing patient-affordability business carried the shares to a $14.96 closing high on 8 October 2026, level with the $15 analyst targets. The third-quarter report, expected around 11 November 2026, settles whether active… Distinct case · Fintech & consumer credit analysed · PENG Penguin Solutions, Inc. Medium Penguin Solutions' memory-led AI-infrastructure case strengthened after the 6 October beat and a fiscal 2027 sales outlook of about 40% growth. The early-January fiscal first-quarter report shows whether Integrated Memory growth holds. Picks and shovels · AI datacenter infrastructure catalyst · PLTR Palantir Technologies Inc. Medium Palantir Technologies' near-90% revenue growth and a 8 October 2026 Goldman Sachs upgrade have lifted the shares to $198.78, near their high; the third-quarter report, expected around 2 November, shows whether revenue meets the… Theme leader · AI enterprise software · Defense & aerospace catalyst · PMTS CPI Card Group Inc. Medium CPI Card Group's free-cash-flow and debt-reduction case holds with the shares at $25.00 on 8 October 2026; the third-quarter report, expected 3 November 2026 or 11-04, decides whether margins back the $45–50 million cash forecast. Picks and shovels · Fintech & consumer credit catalyst · PSIX Power Solutions International, Inc. Medium Power Solutions International's case rests on data-center generator engine demand lifting second-half 2026 sales above the first half with gross margin at 27.1% or better; the third-quarter report, expected 5 November 2026 against a $206.8… Picks and shovels · AI datacenter infrastructure catalyst · PSX Phillips 66 Medium the 28 October 2026 third-quarter report shows whether the realized refining margin held at or above the second quarter's $24.08 per barrel. Theme leader · Oil, energy & geopolitical catalyst · PUBM PubMatic, Inc. Medium PubMatic's year-over-year ad revenue recovery, a new Sony connected-TV partnership and a favourable Google remedy ruling hold the shares near their high; the Q3 2026 report, expected 5 November to 9 November 2026, must show revenue at or… Business pivot · AI enterprise software catalyst · QLYS Qualys, Inc. Medium Qualys shares trade just below their $199.93 52-week high after a sector-wide Cybersecurity rally, above the $179.36 consensus target; the Q3 report expected around 3 November 2026 shows whether revenue clears the $185.5 million guidance… Business pivot · Cybersecurity catalyst · RCEL Avita Medical, Inc. Medium AVITA Medical's shares closed at a $13.33 52-week high on 8 October 2026 on guidance alone: $86–89 million of 2026 revenue and fourth-quarter cash-flow breakeven. The third-quarter report, expected around 5 November 2026, shows whether… Distinct case · Medtech & diagnostics catalyst · RCMT RCM Technologies, Inc. Medium RCM Technologies' shares sit at a 52-week high because energy-services work made Engineering its growth engine; the Q3 report, estimated for early-to-mid November 2026, must show Engineering revenue above $39.5 million and gross margin of… Picks and shovels · Cyclical industrials · Industrial power & grid catalyst · RKLB Rocket Lab Corporation Medium Rocket Lab's revenue growth has to outrun the share dilution that funded its Iridium acquisition; third-quarter 2026 revenue of at least the $250 million guidance floor, expected ~9 November 2026, settles it. Theme leader · Space economy analysed · RNG Ringcentral, Inc. Medium RingCentral's shares have risen 86.7% in three months as investors price its cloud-communications business as an AI growth story; the 22 October 2026 third-quarter report decides whether revenue clears the $664–670 million guidance and… Business pivot · AI enterprise software catalyst · RTX RTX Corporation Medium RTX Corporation keeps adding missile contracts, including a $6.3 billion SM-3 award on 8 October 2026, while its shares sit 18.3% below their high in a defense-sector selloff; the 20 October 2026 third-quarter report shows whether earnings… Theme leader · Defense & aerospace catalyst · S SentinelOne, Inc. Medium SentinelOne's shares hold near a 52-week high on its AI-security story while net new recurring revenue grew only 4% and executives sold into the rally; OneCon 2026 on 20 October 2026 and the early-December Q3 report decide whether results… Second-order beneficiary · Cybersecurity catalyst · SEI Solaris Energy Infrastructure, Inc. Medium Solaris Energy Infrastructure's raised data-center power guidance and funded $1.25 billion build-out still support the shares after a rate-driven pullback to $73.08. The third-quarter report, expected around 3 November 2026, shows whether… Picks and shovels · AI datacenter infrastructure catalyst · SG Sweetgreen, Inc. Medium Sweetgreen's shares have extended their recovery from the summer cyclospora outbreak to $9.57, above every consensus target; the third-quarter report, expected around 5 November 2026, decides whether comparable sales confirm the recovery. Crowd-driven · Consumer discretionary rotation catalyst · SGHT Sight Sciences, Inc. Medium Sight Sciences' TearCare dry-eye treatment is becoming a reimbursed second revenue line beside its OMNI glaucoma devices; the third-quarter report expected around 5 November 2026 shows whether dry-eye sales support the raised $88–92… Distinct case · Medtech & diagnostics catalyst · SHOP Shopify Inc. Medium Shopify is growing revenue above 30% a year and is the checkout layer for Meta's Muse shopping agent; its third-quarter 2026 report on 3 November 2026 shows whether low-thirties revenue growth and gross profit held up. Second-order beneficiary · AI enterprise software catalyst · SIBN SI-BONE, Inc. Medium SI-BONE's 15% revenue growth, new Onyx spinal implant and higher Medicare fusion payments support a recovery case; the third-quarter report, expected around 9 November 2026, shows whether revenue holds the $231–233 million 2026 outlook. Distinct case · Medtech & diagnostics analysed · SIG Signet Jewelers Limited Medium Signet Jewelers is earning more on flat sales, with fiscal 2027 adjusted EPS guidance raised to $10.45–$12.15 and a $125 million buyback under way. The third-quarter report, expected around 1 December 2026, shows whether that range… Business pivot · Consumer discretionary rotation catalyst · SILC Silicom Ltd Medium Silicom's networking-card revenue rose 59% in Q2 2026 and a first AI inference order adds a second growth line, with the shares now back below Needham's $60 target. The 29 October 2026 third-quarter report shows whether revenue meets the… Second-order beneficiary · Networking & optical catalyst · SIMO Silicon Motion Technology Corporation Medium Silicon Motion's enterprise SSD-controller ramp has to deliver third-quarter 2026 revenue of at least $519 million, the low end of guidance. The 28 October report settles it, after the shares fell 8.4% with memory stocks on 8 October. Picks and shovels · AI chips & memory catalyst · SMMT Summit Therapeutics Inc. Medium Summit Therapeutics' case rests on FDA approval of ivonescimab by 14 November 2026, now funded by AstraZeneca's closed $2.0 billion investment. Full biliary-cancer data at ESMO on 25 October 2026 and the FDA decision settle it. Event-driven · Binary-catalyst biotech · Oncology & immunology catalyst · SMTC Semtech Corporation Medium Semtech's data-center interconnect growth lifted the shares 41.9% in three months to a $197.20 closing high; the 15 October 2026 teach-in targets and a fiscal Q3 report inside the $405–415 million outlook decide whether the advance holds. Picks and shovels · Networking & optical · Analog semiconductors catalyst · SNOW Snowflake Inc. Medium Snowflake's AI-driven consumption growth, with product revenue up 37% in the 2 September 2026 report, has lifted the shares to $343.40, 3.7% under their $356.47 high despite $3.75 billion of new convertibles. The ~2 December 2026 Q3 report… Picks and shovels · AI enterprise software catalyst · SOPH SOPHiA GENETICS SA Medium SOPHiA GENETICS' cloud genomics platform is still growing faster than its guide, with Q2 revenue up 27% and a new Myriad prostate-cancer deal on 8 October 2026; the Q3 report, estimated for 3 November 2026, shows whether the $94–96 million… Second-order beneficiary · Medtech & diagnostics catalyst · STLN Starling Oncology, Inc. Medium Starling Oncology's shift to capitated oncology contracts is lifting gross profit faster than revenue; the third-quarter 2026 report, estimated for 12 November, settles whether adjusted EBITDA lands in the guided $500,000–$1.5 million… Business pivot · Managed care & health services catalyst · TEAM Atlassian Corporation Medium Atlassian's cloud business, up 31% in the June quarter, and new OpenAI-powered agents have carried the shares to a 52-week high; the 5 November 2026 report shows whether cloud growth meets the guided ~28.5% on $1,705–1,715 million revenue. Second-order beneficiary · AI enterprise software catalyst · TEN Tsakos Energy Navigation Ltd. Medium Tsakos Energy Navigation's earnings are rising with crude tanker rates that hit new all-time highs in early October 2026, and management said the third quarter is tracking ahead of the second. The report expected around 19 November 2026… Theme leader · Oil, energy & geopolitical · Freight & logistics analysed · TSEM Tower Semiconductor Ltd. Medium Tower Semiconductor's silicon-photonics foundry business is shipping in volume against contracted 2027 demand, and the 8 October optics sell-off carried no company news; the mid-November third-quarter report settles whether revenue lands… Picks and shovels · Semi foundry & equipment · Networking & optical catalyst · TSSI TSS, Inc. Medium TSS, Inc.'s pivot to higher-margin AI rack integration is lifting profit while total sales shrink; the third-quarter report, expected around 16 November, settles whether integration revenue tops the second quarter's $13.9 million. Picks and shovels · AI datacenter infrastructure catalyst · TXN Texas Instruments Incorporated Medium Texas Instruments' analog recovery and October price increases still support the shares after a 8 October 2026 close of $288.20; the 21 October 2026 third-quarter report must land revenue inside the $5.65–6.15 billion guide to confirm it. Second-order beneficiary · Analog semiconductors catalyst · U Unity Software Inc. Medium Unity Software's advertising business is carrying its turnaround, and a 7 October 2026 Google AI game-creation partnership adds a second story. The Q3 2026 report, expected around 5 November 2026, settles it: Strategic Grow revenue must… Business pivot · AI enterprise software catalyst · VEON VEON Ltd. ADS Medium VEON's fast-growing digital businesses led it to raise 2026 revenue guidance to 15%-18% growth and expand its buyback to about $200 million; the 6 November 2026 third-quarter report shows whether profit margins keep pace. Business pivot · Emerging markets catalyst · VICR Vicor Corporation Medium Vicor Corporation's patent royalties on its Vertical Power Delivery technology drove two September guidance raises to more than 30% sequential growth; the 20 October 2026 third-quarter report shows whether those royalties recur after the… Picks and shovels · AI datacenter infrastructure catalyst · VLO Valero Energy Corporation Medium Valero Energy's record share price rests on diesel refining margins that a 100 million barrel G7 stock release is now testing. The 22 October third-quarter report shows whether realized margins and fourth-quarter commentary hold up. Theme leader · Oil, energy & geopolitical catalyst · VSTM Verastem, Inc. Medium Verastem's shares turn on the 14 October 2026 first efficacy readout for VS-7375, its oral KRAS G12D cancer drug, backed by a $25.1 million-a-quarter ovarian-cancer launch. Pancreatic and lung response rates, set against a rival's 50%… Event-driven · Oncology & immunology · Binary-catalyst biotech catalyst · WT WisdomTree, Inc. Medium WisdomTree's record $174 billion of assets and $12.3 billion of year-to-date inflows support further fee growth; the third-quarter report due about 30 October 2026 settles it by showing whether operating revenue tops $177.2 million. Distinct case catalyst · XGN Exagen Inc. Medium Exagen's autoimmune-testing business is growing test volume and price per test, with the shares at $8.17 on 8 October 2026, 31.7% below their 52-week high; the third-quarter report, listed for about 11 November 2026, shows whether the… Distinct case · Medtech & diagnostics catalyst · XMTR Xometry, Inc. Medium Xometry's AI-assisted manufacturing marketplace has held its shares near a record $110.66 close on raised August guidance. The third-quarter report, expected around 4 November 2026, settles it on revenue of at least $234 million and… Second-order beneficiary · Cyclical industrials catalyst · ZBRA Zebra Technologies Corporation Medium Zebra Technologies' raised 2026 earnings outlook has lifted the shares to within 1% of their $386.05 52-week high. The Q3 report on 3 November 2026 shows whether adjusted EPS clears the guided $4.70–$4.90 and supports a 43.3% three-month… Second-order beneficiary · Physical AI & robotics catalyst · ZLAB Zai Lab Limited Medium Zai Lab's re-rating case rests on first-line small-cell lung cancer data for its DLL3 drug zoci at ESMO on 26 October 2026; a registrational Phase 3 start announced by 31 December 2026 would confirm it. Event-driven · Oncology & immunology · Binary-catalyst biotech catalyst · ZS Zscaler, Inc. Medium Zscaler's 6 October investor day reaffirmed fiscal 2027 guidance and set a path to more than $8 billion of recurring revenue by fiscal 2031, lifting analyst targets; the late-November or early-December report shows whether revenue beats… Theme leader · Cybersecurity analysed · AAPL Apple Inc. Low Apple's shares sit 0.2% below their 52-week high with much of the premium iPhone and foldable cycle priced in, and analysts say memory costs offset the revenue gains. The 16 October 2026 iPhone Duo preorders and the 2 November 2026 fiscal… Event-driven · Mega-cap AI platforms catalyst · ABCL AbCellera Biologics Inc. Low AbCellera's shares rest on whether ABCL635, its injectable hot-flash antibody, keeps working well beyond week 4. The 12-week data guided for year-end settle it. With the 1 October 2026 IMS presentation over and no new readout before then,… Event-driven · Precision biotech & therapeutics analysed · ABSI Absci Corporation Low Absci Corporation's shares still turn on whether its antibody ABS-201 grows human hair better than placebo; the interim HEADLINE readout, guided for the second half of 2026, settles the case by 31 December 2026. Event-driven · Precision biotech & therapeutics analysed · ADBE Adobe Inc. Low Adobe keeps beating forecasts, yet AI-agent fears hold the shares 33% below their 52-week high; the mid-December fourth-quarter report tests whether recurring-revenue growth holds near the 10.2% target. Business pivot · AI enterprise software analysed · AFRM Affirm Holdings, Inc. Low Affirm's operating case is intact, with fiscal 2027 guidance and higher analyst targets, but the shares closed at $70.43 on 1 October 2026 without following; the report due about 5 November 2026 settles whether revenue confirms guidance. Theme leader · Fintech & consumer credit analysed · AGM Federal Agricultural Mortgage Corporation Low Federal Agricultural Mortgage Corporation (Farmer Mac) still grows earnings from infrastructure lending, but its shares slipped below $210 after the September index addition. The early-November third-quarter report decides whether spread… Second-order beneficiary · Industrial power & grid analysed · ALAB Astera Labs, Inc. Low Astera Labs' Scorpio switch ramp still supports guided third-quarter revenue of $540–560 million, but the shares gave back their index-speculation rally to close at $347.05 on 8 October 2026. The 3 November 2026 report decides whether that… Picks and shovels · Networking & optical · AI datacenter infrastructure catalyst · AMZN Amazon.com, Inc. Low Amazon.com's case rests on Amazon Web Services growing fast enough to pay for about $220 billion of 2026 infrastructure spending. The third-quarter report, estimated for 29 October 2026, shows whether cloud growth holds near the June… Theme leader · Mega-cap AI platforms · AI datacenter infrastructure catalyst · ARM Arm Holdings plc Low Arm Holdings shares have erased their late-September AI-agent CPU rally while a Qualcomm trial puts royalties in dispute; the tentative 4 November 2026 report must beat the ~13% royalty-growth guide to revive the case. Picks and shovels · AI chips & memory catalyst · ASO Academy Sports and Outdoors, Inc. Low Academy Sports and Outdoors raised fiscal 2026 EPS guidance on one-time tariff refunds and buybacks while comparable sales fell 0.4%; the ~8 December 2026 third-quarter report shows whether core demand supports the rally. Business pivot · Consumer discretionary rotation analysed · ASST Strive, Inc. Low Strive, Inc. is still growing bitcoin per share, but its shares have fallen with bitcoin and on dilution worries; the weekly Form 8-K due around 13 October 2026 shows whether per-share gains continue with bitcoin below the treasury's… Theme leader · Crypto exchanges & financials catalyst · AVGO Broadcom Inc. Low Broadcom's AI-chip revenue is still compounding, but a $60 billion debt package now funds Anthropic's Broadcom chips; the planned 9 December 2026 Q4 report against a $21.7 billion AI-revenue guide settles the case. Picks and shovels · AI chips & memory · AI datacenter infrastructure catalyst · BA The Boeing Company Low Boeing's case now rests on its commercial losses more than on the regulator: the FAA ruled on 2 October 2026 that the 737 MAX 10 software glitch is not a safety issue. The 27 October 2026 third-quarter report shows whether margins and cash… Business pivot · Defense & aerospace catalyst · BAC Bank of America Corporation Low Bank of America's shares closed at $53.61 on 8 October 2026, oversold after a warning that investment-banking fees will fall more than 10%; the 14 October 2026 third-quarter report shows whether earnings have turned or only sentiment has. Event-driven catalyst · BRK.B Berkshire Hathaway Inc. Low Berkshire Hathaway is spending its cash under Greg Abel on buybacks and new stakes such as Lennar, but its shares still trail the S&P 500. The third-quarter report due around 7 November 2026 shows whether repurchases held up and insurance… Business pivot catalyst · CAT Caterpillar Inc. Low Caterpillar's record $72 billion backlog has not protected its shares from 30-year Treasury yields at a 24-year high and a federal farm-equipment inquiry. The third-quarter report, expected around 28 October 2026, shows whether orders held… Picks and shovels · Cyclical industrials · Industrial power & grid catalyst · COIN Coinbase Global, Inc. fresh Low Coinbase Global shares still trade on bitcoin because its new clearing, Citigroup and Deribit businesses have not yet reached revenue. The third-quarter report, expected around 29 October 2026, shows whether subscription-and-services… Theme leader · Crypto exchanges & financials catalyst · COST Costco Wholesale Corporation Low Costco Wholesale shares look more likely to track the S&P 500 than beat it, because adjusted monthly sales growth slowed from 8% in May to 5.4% in August at about 40 times forward earnings. September sales, due after the close on 7 October… Theme leader catalyst · CRM Salesforce, Inc. Low Salesforce has measurable AI-agent revenue, but the story is well known and the shares have slid to $227.80 since Dreamforce. The ~2 December 2026 third-quarter report decides whether organic growth reaccelerates beyond acquisitions. Business pivot · AI enterprise software analysed · CVI CVR ENERGY, INC. Low CVR Energy's third-quarter refining margin should beat the second quarter's $9.94 a barrel on record diesel cracks, but the shares already rose 88.8% in three months; the report due around 28 October 2026 shows whether the margin justifies… Theme leader · Oil, energy & geopolitical catalyst · DGXX Digi Power X Inc. Subordinate Voting Shares Low Digi Power X's AI-infrastructure pivot hinges on bringing Phase 1 of its Alabama colocation campus into service in December 2026; that delivery and the mid-November quarterly report decide whether its $1.1 billion contract becomes revenue. Business pivot · AI datacenter infrastructure · GPU cloud & neoclouds analysed · DIS The Walt Disney Company Low The Walt Disney Company's parks and streaming profits are growing faster than its share price, now in a correction with targets trimmed; the 12 November 2026 fiscal Q4 report shows whether double-digit fiscal 2027 EPS growth guidance holds. Business pivot · Travel & leisure catalyst · FOSL Fossil Group, Inc. Low Fossil Group's shares hit a 52-week high of $6.80 on 1 October 2026 on the margin turnaround reported in August. The estimated mid-November Q3 report decides whether cash flow and Q4 sales growth confirm it. Business pivot · Consumer discretionary rotation catalyst · FSOL Fidelity Solana Fund Low Fidelity Solana Fund is more likely to lag the S&P 500 over three months because US spot Solana funds have turned to October outflows and SOL lost its $116 support; weekly flow tallies and Alpenglow's mainnet timing decide whether that… Theme leader · Crypto exchanges & financials catalyst · GE GE Aerospace Low GE Aerospace's engine-services growth and raised 2026 guidance have not stopped its shares sliding to $305.62, 19.7% below their 52-week high; the 20 October 2026 third-quarter report shows whether margins and 2027 commentary can halt the… Theme leader · Defense & aerospace catalyst · GRAL GRAIL, Inc. Low GRAIL's shares already price in FDA approval of its Galleri cancer blood test and slipped to $132.61 on 8 October 2026 as new trial data arrived. An FDA approval for adults 50 and older before a weekly close below $106.19 settles the case. Event-driven · Medtech & diagnostics catalyst · HBB Hamilton Beach Brands Holding Company Low Hamilton Beach Brands' shares have run ahead of the evidence after a 70.8% three-month rise built on tariff refunds. The ~4 November 2026 third-quarter report decides whether gross margin excluding refunds of at least 26.1% and the… Distinct case · Consumer discretionary rotation analysed · HD The Home Depot, Inc. Low Home Depot's results are holding up better than its shares, which sit 22.8% below their 52-week high as mortgage rates climb; the third-quarter report expected 17 November 2026 shows whether fiscal 2026 guidance survives. Business pivot · Housing, homebuilders & proptech catalyst · HNI HNI Corporation Low HNI Corporation's case rests on Steelcase cost savings lifting earnings while sales stay flat; the late-October third-quarter report decides whether July's 20–25% earnings-growth outlook survives softer office-furniture demand. Business pivot · Cyclical industrials catalyst · HNST The Honest Company, Inc. Low The Honest Company's turnaround case depends on organic growth and margins excluding tariff refunds holding at Q2 levels. The Q3 2026 report, expected around 11 November, settles it, and momentum has faded beforehand. Business pivot analysed · HOOD Robinhood Markets, Inc. Low Robinhood Markets has strong third-quarter trading volumes, but its shares have slid back to the early-September low as bitcoin fell; the 27 October Q3 report decides whether earnings are strong enough to reverse the slide. Theme leader · Crypto exchanges & financials · Prediction markets & betting catalyst · IBM International Business Machines Corporation Low IBM's move into software and enterprise AI has not lifted its shares since a second-quarter revenue miss and a guidance cut; the 21 October 2026 third-quarter report shows whether software growth steadies or the 4%-5% revenue outlook falls… Business pivot · AI enterprise software · Quantum computing catalyst · ILMN Illumina, Inc. Low Illumina's clinical sequencing recovery is intact, but the shares slid to $264.57 on 8 October 2026 after reversing from a $309.35 intraday high on 6 October 2026; the confirmed 29 October 2026 third-quarter report must beat the… Business pivot · Medtech & diagnostics catalyst · IMOS ChipMOS TECHNOLOGIES INC. Low ChipMOS posted record third-quarter 2026 revenue of NT$8,400.8 million, but monthly sales were flat from August to September and its US shares already price in more. Third-quarter margins, expected around 10 November 2026, settle whether… Second-order beneficiary · Semi foundry & equipment analysed · INTR Inter & Co. Inc. Class A Low Inter & Co.'s record profits now come with an election-driven 32% four-day jump in its shares; Brazil's 25 October 2026 presidential runoff decides whether the rally holds, and third-quarter results test the earnings side. Event-driven · Emerging markets catalyst · ITGR Integer Holdings Corporation Low Integer Holdings Corporation is close to completing its $127.00 cash sale to KKR after U.S. antitrust clearance on 30 September 2026, and the 21 October 2026 shareholder vote is the last major step; the fixed payout leaves the shares… Event-driven · M&A & special situations · Medtech & diagnostics catalyst · JILL J.Jill, Inc. Low J.Jill's turnaround looks priced in, with shares at $24.76 on 6 October 2026, at the $25 top of broker targets, and TowerBrook's 49.4% stake registered for resale; the early-December third-quarter report shows whether guided 3%–5% sales… Distinct case · Consumer discretionary rotation catalyst · JNJ Johnson & Johnson Low Johnson & Johnson's newer drugs are covering lost Stelara sales, yet the shares fell to $252.93 on 5 October 2026, just above $250; the 13 October 2026 third-quarter report shows whether that growth and the $101.1 billion 2026 sales… Business pivot · Oncology & immunology · Medtech & diagnostics catalyst · KO The Coca-Cola Company Low Coca-Cola is running ahead of its raised 2026 plan and gaining ground as PepsiCo stumbles, but the defensive shares have little edge over the S&P 500; the 27 October 2026 third-quarter report shows whether about 5% organic growth holds. Business pivot catalyst · KOD Kodiak Sciences Inc Low Kodiak Sciences' DAYBREAK win in wet AMD looks largely priced in, with the shares near the consensus target, deeply overbought and a launch still unfunded. The 9 October 2026 AAO data, the third-quarter funding plan and December's PEAK… Event-driven · Precision biotech & therapeutics catalyst · LIFE Ethos Technologies Inc. Low Ethos Technologies' growth case is now contested by two short-seller reports on its reliance on multilevel-marketing agencies and a JPMorgan downgrade; the early-November third-quarter report, against a $160–164 million revenue outlook,… Distinct case · Fintech & consumer credit analysed · LMT Lockheed Martin Corporation Low Lockheed Martin's business is running ahead of plan, with a record $230 billion backlog and raised 2026 guidance, but its shares remain caught in a sector-wide defense sell-off. The 22 October 2026 third-quarter report shows whether… Theme leader · Defense & aerospace · Space economy catalyst · LUXE LuxExperience B.V. Low LuxExperience's turnaround has lifted the shares near their $10.51 annual high and above most analyst targets; the fiscal first-quarter report, expected around 11 November 2026, decides whether profits keep improving. Business pivot · Consumer discretionary rotation analysed · MAN ManpowerGroup Low ManpowerGroup's staffing recovery is priced ahead of proof after a 43.3% three-month gain; the 15 October 2026 third-quarter report shows whether earnings reach the company's $0.96–$1.06 per-share guidance. Event-driven · Cyclical industrials · Managed care & health services catalyst · MCD McDonald's Corporation Low McDonald's shares sit near a four-year low as analysts cut targets on the cost of its $8.5 billion franchisee support plan and falling US traffic. The third-quarter report, estimated for 4 November 2026, shows whether US guest counts have… Business pivot · Consumer discretionary rotation catalyst · MRNA Moderna, Inc. Low Moderna's shares price in a strong Phase 3 melanoma result for its Merck-partnered cancer vaccine intismeran autogene. The 24 October 2026 ESMO presentation of the INTerpath-001 effect size settles whether the 194% three-month advance… Event-driven · Precision biotech & therapeutics catalyst · MSTR Strategy Inc Low Strategy Inc. is still adding bitcoin, but most of its spending now goes to STRC preferred buybacks: $176.3 million against $28.7 million of bitcoin from Sept 28 to Oct 4, 2026. The 28 October dividend vote and third-quarter results decide… Theme leader · Crypto exchanges & financials catalyst · MXL MaxLinear, Inc. Low MaxLinear's shares fell 13% to $93.70 on 8 October 2026 after a 45% one-month rally yet still sit above the $88.64 average analyst target; the 22 October 2026 third-quarter report must show revenue above the $220 million guidance ceiling… Picks and shovels · Analog semiconductors catalyst · MYGN Myriad Genetics, Inc. Low Myriad Genetics shares trade on one broker's $8 recovery call while revenue per test is still falling; the third-quarter report, expected around 2 November 2026, shows whether pricing has bottomed. Business pivot · Medtech & diagnostics catalyst · NAT Nordic American Tanker Low Nordic American Tankers' shares sit near a 52-week high on record suezmax freight rates but already trade above analysts' targets; the late-November third-quarter report decides whether fleet earnings top Q2's $63,000 a day. Theme leader · Oil, energy & geopolitical analysed · NFLX Netflix, Inc. Low Netflix still grows revenue at double digits with a 33% margin, but YouTube's gains in US viewing time keep its shares 42.3% below their high as analysts cut targets; the 20 October 2026 third-quarter report shows whether revenue and… Theme leader catalyst · NKE Nike, Inc. Low NIKE's sales slide now carries a credit cost: S&P Global Ratings cut NIKE to A on 5 October 2026 and expects cash burn after dividends for two to three years. The shares are likelier to lag the S&P 500 until the ~17 December 2026… Business pivot · Consumer discretionary rotation analysed · NTAP NetApp, Inc. Low NetApp's flash-storage growth and raised fiscal-2027 outlook back its AI-infrastructure pivot, but a record $226.27 close on 2 October 2026 sits above nearly every analyst target. The fiscal-Q2 report, expected around 1 December 2026,… Business pivot · AI datacenter infrastructure analysed · NTRA Natera, Inc. Low Natera's Signatera test is lifting revenue 38%, but the shares fell to a $390.79 close on 8 October 2026 despite target raises from Citi and Barclays; the Q3 2026 report, estimated for 5 November–11, shows whether growth justifies the… Theme leader · Medtech & diagnostics catalyst · OABI OmniAb, Inc. Low OmniAb's shares need partner milestone payments to repeat and lift 2026 revenue guidance above $36 million; the third-quarter report expected around 5 November 2026 decides it, after the shares closed lower on the 6 October 2026 Analyst… Picks and shovels · Precision biotech & therapeutics catalyst · OKTA Okta, Inc. Low Okta's shares now fully price its role as the identity layer for AI agents, closing at a $220.21 high on 8 October 2026 near the $223 median target before any reported figure confirms it. The Q3 fiscal 2027 report, expected around 1… Distinct case · Cybersecurity catalyst · ORCL Oracle Corporation Low Oracle's $664 billion cloud backlog is converting to revenue, but doubts over OpenAI's revenue and new off-balance-sheet chip financing keep the shares under pressure. The 28 October 2026 analyst day shows whether Oracle sets a dated path… Business pivot · AI datacenter infrastructure · GPU cloud & neoclouds catalyst · P Everpure, Inc. Low Everpure's $7.0–7.3 billion fiscal-2028 revenue outlook has lifted the shares to a record $143.88 close, at or above most average analyst targets with momentum at an extreme. The third-quarter report around 2 December 2026 shows whether… Picks and shovels · AI datacenter infrastructure analysed · PEP PepsiCo, Inc. Low PepsiCo cut its 2026 core earnings-growth outlook to 1–2% on 8 October 2026 despite a sales beat, as input costs and falling North American snack profit outweigh growth abroad. The early-2027 fourth-quarter report and volume after… Business pivot analysed · PG The Procter & Gamble Company Low Procter & Gamble's organic sales growth stalled at 0% last quarter, and the shares are more likely to lag than lead the S&P 500 until volume returns. The 22 October 2026 fiscal first-quarter report shows whether growth is moving toward the… Business pivot catalyst · PSNL Personalis, Inc. Low Personalis trades as a fixed $16.25-per-share claim on Tempus AI's agreed takeover, leaving little room to beat the market; the 2 October 2026 US antitrust waiting-period expiry and any binding higher offer settle it. Event-driven · Medtech & diagnostics · Oncology & immunology analysed · QCOM QUALCOMM Incorporated Low Qualcomm's data-center pivot rests on its Amazon partnership while its handset business loses most of its Apple modem revenue; the 11 November 2026 report settles whether first data-center sales and the $5 billion fiscal 2027 target hold. Business pivot · AI chips & memory analysed · QTRX Quanterix Corporation Low Quanterix's shares, at $3.21 on 8 October 2026, still trade above the $3.00 consensus target despite reduced $142–148 million 2026 revenue guidance and a new China clearance. The third-quarter report, expected around 9 November 2026, will… Distinct case · Medtech & diagnostics catalyst · RBRK Rubrik, Inc. Low Rubrik's 33% subscription ARR growth supports the business, but the shares already trade at the $120 consensus target. The early-December report decides whether guidance rises enough to justify more gains. Second-order beneficiary · Cybersecurity analysed · ROG Rogers Corporation Low Rogers Corporation's 2030 plan for $1.5 billion of revenue and $14.00 of adjusted EPS is already reflected in overbought shares. The late-October third-quarter report decides whether the core materials business delivers the guided $233–243… Business pivot · Analog semiconductors catalyst · RPD Rapid7, Inc. Low Rapid7's turnaround rests on cost cuts lifting margins while its recurring revenue shrinks. The early-November Q3 report settles it: annualized recurring revenue needs to reach the roughly $812 million forecast and management needs to… Event-driven · Cybersecurity analysed · RVTY Revvity, Inc. Low Revvity's case rests on AI drug-discovery customers turning a record instrument backlog into Life Sciences growth; the 3 November 2026 third-quarter report shows whether that segment returns to positive organic growth after a 37%… Second-order beneficiary · Medtech & diagnostics catalyst · RXRX Recursion Pharmaceuticals, Inc. Low Recursion Pharmaceuticals' early-October short-covering spike has faded, leaving the shares priced on pipeline hope while revenue shrinks; the REC-4881 polyposis data at the 2 November 2026 CGA-IGC plenary decide whether the lead drug can… Second-order beneficiary · Precision biotech & therapeutics catalyst · SBET SharpLink, Inc. Low SharpLink, Inc. Still trades below the value of its Ether, at 0.82 times net asset value on The Block's 2 October 2026 tracker. MSCI's index-eligibility ruling, due by 16 October 2026, decides whether that discount can close. Business pivot · Crypto exchanges & financials catalyst · SBS COMPANHIA DE SANEAMENTO B SICO DO ESTADO DE SAO PAULO-SABESP ADS'S Low Sabesp's shares now trade on Brazil's 25 October presidential runoff more than on its water business: the first-round rally lifted the ADS to $6.59, near the $6.736 average analyst target. The runoff and the November quarterly report… Event-driven · Emerging markets catalyst · SDGR Schrodinger, Inc. Low Schrödinger's shares still trade well above the $20.80 consensus target after falling 11.3% to $28.90 on 6 October 2026, because software revenue has not confirmed 27% contract growth; the third-quarter report, estimated for about 4… Second-order beneficiary · Precision biotech & therapeutics catalyst · TENB Tenable Holdings, Inc. Low Tenable's platform pivot shows in its reported mix, but guidance still caps 2026 revenue growth below 10%; the Q3 report, estimated for 4 November 2026, settles whether revenue clears the $273.0 million guidance ceiling. Business pivot · Cybersecurity · AI enterprise software analysed · TRMD TORM plc Low TORM plc's shares closed at a 52-week high of $38.80 on 1 October 2026, above Evercore ISI's $38 target, after Hafnia's stake-building and a raised 2026 earnings forecast. The 4 November 2026 third-quarter report decides whether lower… Theme leader · Oil, energy & geopolitical analysed · TSLA Tesla, Inc. Low Tesla's third-quarter delivery beat ended the near-term volume worry, but a 1.4% second-quarter operating margin leaves the profit case unproven. The 21 October 2026 earnings report shows whether margins and Cybercab disclosure catch up. Theme leader · EV & autonomous mobility · Physical AI & robotics catalyst · TWLO Twilio Inc. Low Twilio's rally on consumer AI agents stalled in its first S&P 500 session, closing at $280.41 on 6 October 2026; the Q3 2026 report, expected about 29 October 2026, shows whether organic growth beats the 11–12% guidance. Business pivot · AI enterprise software catalyst · TWST Twist Bioscience Corporation Low Twist Bioscience's 23% revenue growth as an AI antibody-data supplier is real, but its shares fell to a $152.05 close on 8 October 2026, 25.8% below the 5 October 2026 high, amid ARK and insider selling. The mid-November fiscal Q4 report… Second-order beneficiary · Medtech & diagnostics analysed · TXG 10x Genomics, Inc. Low 10x Genomics' shares, at $80.66 after a 17.5% one-day drop from a $97.74 high, still trade far above the business its new Atera instrument has yet to lift; the third-quarter report, expected around 4 November 2026, tests the 40-unit plan… Business pivot · Medtech & diagnostics catalyst · UBER Uber Technologies, Inc. Low Uber Technologies' ride and delivery business is guided to grow bookings 18–22% while its shares sit near their 52-week low on robotaxi fears and a costly delivery buying spree; the 4 November 2026 third-quarter report shows whether growth… Business pivot · EV & autonomous mobility catalyst · UNH Unitedhealth Group Incorporated Low UnitedHealth Group's case rests on its raised $19.50–$20.00 2026 EPS outlook, which the shares have not confirmed after a 13.0% three-month fall. The 13 October third-quarter report decides whether margin repair holds. Business pivot · Managed care & health services catalyst · V Visa Inc. Low Visa's payment network is still growing double digits, and the shares are back within 2.4% of their $384.14 52-week high. The fiscal 2027 outlook, expected around 27 October 2026, decides whether slowing costs let earnings growth justify a… Theme leader · Fintech & consumer credit catalyst · VECO Veeco Instruments Inc. Low Veeco Instruments closes above the value of the 0.3575 Axcelis shares it would convert into, so a China clearance would more likely pull it down; the ~4 November 2026 third-quarter report shows whether its order recovery holds that premium. Event-driven · Semi foundry & equipment catalyst · VRA Vera Bradley, Inc. Low Vera Bradley's shares have run past published analyst targets on one tariff-refund-aided quarter, so the case now depends on the December third-quarter report showing direct-channel growth without refund help. Business pivot · Consumer discretionary rotation analysed · W Wayfair Inc. Low Wayfair's second-quarter margin recovery has rising analyst support but no price confirmation; the 4 November 2026 third-quarter report shows whether the 6.9% adjusted EBITDA margin repeats. Business pivot · Consumer discretionary rotation catalyst · WFC Wells Fargo & Company Low Wells Fargo's earnings keep rising, but its shares sit near 2026 lows at about 11 times forward earnings after the Fed resumed rate hikes. The 13 October 2026 third-quarter report shows whether loan growth and steadier margins offset… Business pivot catalyst · WMT Walmart Inc. Low Walmart's advertising, membership and e-commerce growth is lifting profit faster than sales, but its shares closed at $110.56 on 8 October 2026, still 17.4% below their high and under the 200-day average at about 40 times earnings. The 19… Business pivot · Consumer discretionary rotation analysed · XOM Exxon Mobil Corporation Low Exxon Mobil is earning heavily on crude back above $105 and strong third-quarter refining margins, but the shares sit at their 52-week high with much of that priced in. The third-quarter report, expected 30 October 2026, and the course of… Theme leader · Oil, energy & geopolitical catalyst · XP XP Inc. Low XP Inc. shares have priced in a market-friendly Brazilian election, rising 84.5% in three months to a record $30.21 close on 8 October 2026. The 25 October 2026 runoff between Flávio Bolsonaro and President Lula settles whether that… Event-driven · Emerging markets catalyst ·

Recently sold

3

Covered

7
BULL Webull Corporation Low Webull Corporation's breakout rebound has failed, with a 30 September 2026 close of $6.97 below the $7.30 level; the mid-November third-quarter report decides whether 51% revenue growth and a 31.5% adjusted margin hold. Crowd-driven · Crypto exchanges & financials · Consumer discretionary rotation catalyst · DSGR Distribution Solutions Group, Inc. Low Distribution Solutions Group's shares trade at $34.94 against a $35.00 cash buyout by LKCM Headwater, so the remaining case is completion, not upside; the definitive proxy and the unaffiliated-holder vote settle it. Event-driven · M&A & special situations analysed · FIVN Five9, Inc. Low Five9's AI revenue, up 78% in the second quarter, drives the case for the shares, but the $34.36 close on 2 October 2026 already matches the $34.33 consensus target. The third-quarter report, expected around 5 November 2026, decides… Business pivot · AI enterprise software analysed · HVT Haverty Furniture Companies, Inc. Low Haverty Furniture Companies' order recovery is real but is losing earnings momentum to freight costs and a Sidoti estimate cut; the estimated 28 October 2026 third-quarter report shows whether written orders and the 60.5%–61.0% margin… Distinct case · Consumer discretionary rotation · Housing, homebuilders & proptech catalyst · KRT Karat Packaging Inc. Low Karat Packaging's shares hit a record $54.57 close on 2 October 2026 on the tariff-refund re-rating; the estimated early-November third-quarter report, the first without a large refund, decides whether 35–37% recurring gross margins… Distinct case · Small-cap value rotation · Cyclical industrials analysed · PAYC Paycom Software, Inc. Low Paycom Software's re-rating needs recurring-revenue growth and margins to beat its own 2026 guidance, and analysts are split after Bank of America's 29 September 2026 Underperform call. The Q3 report, estimated for about 4 November 2026,… Business pivot · AI enterprise software analysed · PD PagerDuty, Inc. Low PagerDuty's cost reset and unresolved ownership question support a recovery case, but the shares sit 5.4% below the 52-week high after a 56.6% three-month gain; fiscal third-quarter results (~24 November 2026, est.) test whether net… Business pivot analysed ·

Common questions

What is a FrontierPicks dossier?

A per-ticker research note written by a frontier language model: the current thesis, the archetype the name is trading as, the next dated catalyst, and an explicit kill line — the price level or event that would prove the pick wrong. Every dossier is dated and rewritten as the facts change.

How many stocks does FrontierPicks cover?

225 US tickers have a dossier right now. All 225 published dossiers include both a dated thesis and a kill line, the price that would prove it wrong. Coverage follows the research: the stocks we hold, the themes on the move, and the largest US companies. 147 stocks are re-read every trading day: every stock in the portfolio or with an open pick, plus those in accelerating themes, reporting soon or moving sharply. The other 78 are re-read on a rolling cycle, and none is more than 6 sessions old.

Is AI-generated stock research reliable?

It should be judged the way any research is judged: on whether its calls beat the market. FrontierPicks is built to make that measurable. Every medium-or-higher conviction pick names its kill line before it opens and is graded against the S&P 500 over the same days on a public scoreboard, losers included. It is research to evaluate, not advice.

How often are the dossiers updated?

On a rolling cycle, not uniformly. 147 stocks are re-read every trading day: every stock in the portfolio or with an open pick, plus those in accelerating themes, reporting soon or moving sharply. The other 78 are re-read on a rolling cycle, and none is more than 6 sessions old. The model re-reads a covered name against fresh price, filing and news data and rewrites the dossier when the facts move; each page shows its own last-updated date rather than a sitewide timestamp, so the cadence is checkable name by name.